Volgenau School of Engineering
George Mason University
George Mason University Mason
George Mason University

Mason Bioengineering Alliance

The Mason Bioengineering Alliance is a distinguished group of accomplished individuals from our biomedical and health sciences community.

The alliance supports the mission and activities of George Mason University’s Department of Bioengineering. The alliance is the critical industry and institutional advisor to the department’s activities and programs, helping to lead the definition and execution of the department’s strategic research plan including the components of education, research, commercialization, and fundraising. This Advisory Board is composed of 31 members:

  • Charles Anamelechi, PhD, Manager – Deloitte Consulting, LLP
  • Jeff Arndt, Senior System Engineer – Centauri Corp
  • Krishna Balakrishnan, Senior Technology Transfer Manager – National Center for Advancing Translational Sciences (NCATS), NIH
  • Peter Basser, Senior Investigator – Intramural Research Program (IRP); NIH Head – Section on Quantitative Imaging and Tissue Sciences (SQITS), Associate Scientific Director (ASD), Division of Imaging, Behavior and Genomic Integrity (DIBGI), and Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH)
  • Robert Caldwell, President & CEO – Strategic Health Solutions, LLC
  • Vizma Carver, Founder and CEO – Carver Global Health Group LLC
  • Jeff Conroy, CEO – Embody
  • Kevin Cleary, PhD, Scientific Lead, The Sheikh Zayed Institute for Pediatric Surgical Innovation – Children's National Medical Center
  • John Deeken, MD, President – Inova Schar Cancer Institute, Inova Fairfax Hospital; Senior Vice President – Inova Health System; Professor of Medicine – University of Virginia
  • Arthur Edge, Technology Manager – GlaxoSmithKline
  • Stanley Thomas Fricke, Director of Medical Physics – Department of Radiology, Georgetown University
  • Thomas Axel Haag, PhD, Managing Partner – Linden Lake Venture Capital
  • David J. Hamilton, PhD, Neuroscience Software Engineer – Northrop Grumman Corporation
  • Jennifer Hammaker, Vice President – Business Development, Maryland Technology Development Corporation (TEDCO)
  • Stephen Hoang, Head of Computational Biology – Hemoshear Therapeutics
  • Richard Hughen, CEO – Linshom
  • Praduman Jain, Founder and CEO – Vibrent Health
  • Erin Johnson, Executive Director of Operations – Vaccines Expansion, Merck
  • Chris Juncosa, Life Sciences Consultant – Dalya Partners
  • Neal Koller, Chairman and CEO – Alphyn Biologics, LLC
  • R. Prakash Kolli, PhD, PE, CEO and Founder – Blue Point Materials Research, LLC
  • John Newby, CEO – VirginiaBio
  • Todd Pantezzi, Vice President – Federal Health Business Development, Perspecta
  • Roland Probst, PhD, Founder and Chief Innovation Officer – ACUITYnano, LLC
  • Steven Roberts, PhD, Venture Analyst – BioHealth Innovation Incorporated
  • Mahesh B. Shenai, MD, MBA, FAANS, Clinical Director of Inova Neurosurgery, Director of Functional and Restorative Neurosurgery – Inova Fairfax Medical Campus
  • Morgan K. Sisk, Modeling & Simulation Engineer – Science Applications International Corporation (SAIC)
  • Michael Tarlov, Chief – Biomolecular Measurement Division, National Institute of Standards and Technology
  • Marinka Tellier, PhD, Director of Regulatory Affairs – NSF International
  • Eric Vollmecke, Executive Vice President – SPGlobal
  • Irving Weinberg, MD, PhD, President – Weinberg Medical Physics, Inc.